MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

MET exon 14 splicing mutations are new targetable oncogenic drivers reported in 3% of non-small cell lung cancer (NSCLC) cases and have been shown to be more common in pulmonary sarcomatoid carcinomas (PSCs). This study sought to screen mutations affecting MET exon 14 splice sites in a large SC coho...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Saffroy, Raphaël, Fallet, Vincent, Girard, Nicolas, Mazieres, Julien, Sibilot, Denis Moro, Lantuejoul, Sylvie, Rouquette, Isabelle, Thivolet-Bejui, Françoise, Vieira, Thibaut, Antoine, Martine, Cadranel, Jacques, Lemoine, Antoinette, Wislez, Marie
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5522077/
https://ncbi.nlm.nih.gov/pubmed/28418914
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.16403
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados